(RVNC) Revance Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Revance Therapeutics | (RVNC) share price targets
Complete technical analysis of Revance Therapeutics (RVNC) by charts plus indicators, forecast predictions and share price targets for Revance Therapeutics (RVNC)
Revance Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Revance Therapeutics is 3748380
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Wed Jan 2025 | 3.64 | 3.65 | 3.66 | 3.64 | 0.244 times |
| 28 Tue Jan 2025 | 3.65 | 3.64 | 3.66 | 3.64 | 0.43 times |
| 27 Mon Jan 2025 | 3.64 | 3.65 | 3.67 | 3.64 | 0.371 times |
| 24 Fri Jan 2025 | 3.65 | 3.67 | 3.69 | 3.65 | 0.176 times |
| 23 Thu Jan 2025 | 3.67 | 3.65 | 3.69 | 3.64 | 0.317 times |
| 22 Wed Jan 2025 | 3.65 | 3.65 | 3.68 | 3.62 | 0.851 times |
| 21 Tue Jan 2025 | 3.67 | 3.64 | 3.67 | 3.64 | 1.48 times |
| 17 Fri Jan 2025 | 3.68 | 3.66 | 3.70 | 3.60 | 2.999 times |
| 17 Fri Jan 2025 | 3.68 | 3.66 | 3.70 | 3.60 | 2.999 times |
| 16 Thu Jan 2025 | 3.27 | 3.28 | 3.30 | 3.25 | 0.176 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 3.7 as stoploss in an intra day sell trade for a target of 3.46. However, stock will show a bullish move above 3.7.
Share price targets for Revance Therapeutics (RVNC)
| Target Type | Value |
| Downside Target | 3.01 |
| Downside Target | 3.11 |
| Downside Target | 3.23 |
| Downside Target | 3.36 |
| Downside Target | 3.50 |
| Downside Target | 3.60 |
| Upside Target | 3.70 |
| Upside Target | 4.68 |
| Upside Target | 5.11 |
| Upside Target | 5.97 |
| Upside Target | 6.09 |
| Upside Target | 6.59 |
Intraday share price targets for Revance Therapeutics (RVNC)
| Target Type | Value |
| Downside Intraday Target | 3.63 |
| Downside Intraday Target | 3.62 |
| Upside Intraday Target | 3.66 |
| Upside Intraday Target | 3.68 |
| Upside Intraday Target | 3.65 |
Weekly technical analysis of Revance Therapeutics (RVNC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Wed Jan 2025 | 3.64 | 3.65 | 3.67 | 3.64 | 0.37 times |
| 24 Fri Jan 2025 | 3.65 | 3.64 | 3.69 | 3.62 | 0.942 times |
| 17 Fri Jan 2025 | 3.68 | 3.66 | 3.70 | 3.60 | 0.72 times |
| 17 Fri Jan 2025 | 3.68 | 3.31 | 3.70 | 3.25 | 2.296 times |
| 10 Fri Jan 2025 | 3.25 | 3.45 | 3.50 | 3.23 | 0.385 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Revance Therapeutics (RVNC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Wed Jan 2025 | 3.64 | 3.04 | 3.70 | 3.03 | 1.163 times |
| 31 Tue Dec 2024 | 3.04 | 3.04 | 3.11 | 3.01 | 1.202 times |
| 26 Tue Nov 2024 | 4.02 | 5.88 | 5.97 | 3.36 | 1.338 times |
| 31 Thu Oct 2024 | 5.90 | 5.23 | 6.09 | 4.68 | 0.36 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Revance Therapeutics (RVNC)
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Revance Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Revance Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Revance Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Revance Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Revance Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.66 and Revance Therapeutics (RVNC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Revance Therapeutics (RVNC) stock. Volume based technical analysis of Revance Therapeutics (RVNC) stock is negative.
Revance Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Revance Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Revance Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Revance Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Revance Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Revance Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.66 and Revance Therapeutics (RVNC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Revance Therapeutics (RVNC) stock. Volume based technical analysis of Revance Therapeutics (RVNC) stock is negative.
Revance Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.